Apyx Medical Announces 510(k) Submission for AYON System
Apyx Medical Corporation (NASDAQ: APYX) is making waves in the aesthetic surgery field with the announcement of its 510(k) premarket notification submission to the U.S. Food and Drug Administration (FDA) for the AYON Body Contouring System. This innovative system utilizes advanced helium plasma and radiofrequency technology, branded as Renuvion, showcasing the company's commitment to elevating surgical capabilities.
AYON Body Contouring System: A Game-Changer
The AYON Body Contouring System is designed to be a versatile all-in-one solution for surgeons. It integrates a range of advanced functionalities that address various patient needs, from fat removal to skin contraction. By streamlining the process, AYON simplifies the surgeon’s workflow and enhances the patient's experience, marking a significant advancement in body contouring.
Key Features of the AYON System
The initial submission of the AYON system includes several key features that optimize its performance:
- Infiltration capabilities for effective fluid delivery.
- Dual aspiration functionality, allowing for simultaneous procedures.
- Ultrasound-assisted liposuction to enhance fat removal precision.
- Electrocoagulation support for excess tissue removal.
- Volume enhancement capability for customized results.
- Integration with Renuvion technology to tackle loose skin effectively.
Future Developments on the Horizon
Looking ahead, Apyx Medical is set to expand the system's indications with an additional submission that will include power-assisted liposuction features. This will broaden the use of AYON in various surgical procedures and further cements the company’s role as a leader in the aesthetic surgery market.
Leadership Insight on AYON's Impact
Charlie Goodwin, President and CEO of Apyx Medical Corporation, expressed enthusiasm about the developments surrounding the AYON system. He emphasized how this new device positions Apyx Medical as a premier entity in the aesthetic surgical industry. Goodwin highlighted that the expedited submission process demonstrates the dedication and capabilities of the research, development, and regulatory teams within the organization.
About Apyx Medical Corporation
Apyx Medical Corporation stands at the forefront of advanced energy technology, passionately aiming to improve lives with innovative medical solutions. Its flagship products, Renuvion and J-Plasma, are specifically tailored for use in cosmetic and hospital surgical markets, offering surgeons the unique capability to apply controlled heat to tissues to achieve optimal results. With support from over 90 clinical studies, Apyx Medical backs its products with proven efficacy.
Expertise and Collaboration
The company's extensive experience with sophisticated waveforms has led to partnerships with various medical device manufacturers, ensuring that state-of-the-art technology is at the disposal of healthcare professionals worldwide.
Frequently Asked Questions
What does the AYON Body Contouring System do?
The AYON Body Contouring System is a versatile all-in-one device designed for comprehensive body contouring, including fat removal and skin contraction.
What innovative features does the AYON system offer?
Key features of AYON include infiltration, dual aspiration, ultrasound-assisted liposuction, and Renuvion treatment for lax skin.
When is the additional 510(k) submission planned?
The company plans to submit an additional 510(k) for power-assisted liposuction later in the year.
How does Apyx Medical support its products?
Apyx supports its Renuvion and J-Plasma products with over 90 clinical documents, illustrating their effectiveness and safety.
Where can I find more information about Apyx Medical Corporation?
For more details about the company and its innovative products, visit the Apyx Medical Corporation website.
